Mameli, Chiara http://orcid.org/0000-0002-6768-3411
Guadagni, Liliana http://orcid.org/0009-0002-3803-4073
Orso, Massimiliano http://orcid.org/0000-0003-0200-1202
Calcaterra, Valeria http://orcid.org/0000-0002-2137-5974
Wasniewska, Malgorzata Gabriela http://orcid.org/0000-0002-8299-2677
Aversa, Tommaso http://orcid.org/0000-0002-1754-6822
Granato, Simona http://orcid.org/0000-0002-3509-1446
Bruschini, Pietro
d’Angela, Daniela http://orcid.org/0000-0003-3409-4757
Spandonaro, Federico http://orcid.org/0000-0003-1388-2850
Polistena, Barbara http://orcid.org/0000-0002-0138-0223
Zuccotti, Gianvincenzo http://orcid.org/0000-0002-2795-9874
Funding for this research was provided by:
Pfizer Italia
Article History
Received: 16 December 2023
Accepted: 9 March 2024
First Online: 18 March 2024
Conflict of interest
: M.G.W. is a consultant for Pfizer, Merck, Sandoz and Novonordisk. C.M. has spoken for Pfizer. T.A. has consulted for Pfizer, and Sandoz. B.P. has received payments or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from the following commercial sources: Allergan, Amgen, Astellas, Baxter, BMS, Boehringer-Ingelheim, Celgene, Eli Lilly, Janssen Cilag, Jazzpharma, Mylan, Nestle´HS, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi, Servier, Shire, Takeda, Teva; in addition, she received consulting fees from UCB. F.S. has received payments or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from the following commercial sources: Allergan, Amgen, Astellas, Baxter, BMS, Boehringer-Ingelheim, Celgene, Eli Lilly, Janssen Cilag, Jazzpharma, Mylan, Nestle´HS, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi, Servier, Shire, Takeda, Teva; in addition, he received consulting fees from Amgen. S.G. and P.B. are employees of Pfizer. C.M., G.Z., V.C., T.A., M.G.W. were paid consultants to Pfizer in connection with the development of this manuscript.